Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 379: 257-268, 2018 05 21.
Article in English | MEDLINE | ID: mdl-29567492

ABSTRACT

The present study is the first to explore the multigenerational effects of mammalian paternal cocaine intake on offspring (F1) circadian clock regulation. Parental cocaine use poses significant health risks to the offspring, through both maternal and paternal drug influences. With respect to the latter, recent evidence suggests that a paternal mode of cocaine inheritance involves epigenetic germ line actions that can ultimately disrupt offspring behavior. Based on our previous report in mice that free-running circadian period (tau) is chronically lengthened following withdrawal from long-term cocaine treatment, the present study was undertaken to explore potential epigenetic effects of paternal exposure to cocaine over the ∼40-day murine spermatogenic cycle on F1 circadian regulatory functions. Here we show that, although withdrawal of sires from the cocaine treatment lengthened their tau, such an effect did not persist in adult F1 male or female offspring born from drug-naïve dams. Notably, however, there was a distinct deficit in the ability of F1 cocaine-sired males, but not females, to undergo light-induced phase delay shifts of the circadian clock. In contrast, F1 cocaine-sired females, but not males, had suppressed circadian phase advance shifting responses to two non-photic stimuli: acute i.p. injections of cocaine and the serotonin agonist ([+]8-OH-DPAT). The reduced cocaine shifting in females was not due to suppressed cocaine-induced behavioral arousal. Collectively, these results reveal that a father's cocaine use can disrupt major circadian entrainment mechanisms in his adult progeny in a sex-dependent manner.


Subject(s)
Circadian Clocks/physiology , Cocaine/adverse effects , Dopamine Uptake Inhibitors/adverse effects , Fathers , Sex Characteristics , 8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacology , Administration, Oral , Animals , Circadian Clocks/drug effects , Epigenesis, Genetic/drug effects , Female , Male , Mice, Inbred C57BL , Motor Activity/drug effects , Motor Activity/physiology , Serotonin Receptor Agonists/pharmacology
2.
Surg Obes Relat Dis ; 2(1): 17-22; discussioon 22-3, 2006.
Article in English | MEDLINE | ID: mdl-16925307

ABSTRACT

BACKGROUND: The purpose of this study was to analyze the frequency and results of preoperative biliary and gastrointestinal (GI) evaluation of patients undergoing Roux-en-Y gastric bypass (RYGB). METHODS: Retrospective review of the preoperative evaluation of 144 consecutive RYGB patients. RESULTS: Cholecystectomy had already been performed in 43 (30%) patients; 22% of those patients with an intact gallbladder had cholelithiasis. Ten patients (7%) had an upper GI x-ray (UGI), and 94 patients (65%) had an esophagogastroduodenoscopy (EGD). Abnormalities were found in 40% of the UGIs and 84% of the EGDs. A total of 96 patients (67%) were tested for Helicobacter pylori; 11% were positive. Twenty-one patients (15%) underwent preoperative colonoscopy; 48% were abnormal, but most of the abnormalities were not clinically significant. Three patients had barium enema x-ray, which was normal in all cases. CONCLUSIONS: The preoperative biliary and GI evaluation of bariatric surgery patients should include a routine ultrasound of the gallbladder. Routine preoperative EGD will detect a significant number of abnormalities that should be treated, but should rarely alter the bariatric surgical procedure or result in denial of bariatric surgery. Many abnormalities will be asymptomatic. Patients should be routinely screened for H. pylori and, if positive, treated before bariatric surgery. Lower GI evaluation should be performed selectively based on the patient's symptoms, physical findings, and guidelines for colorectal cancer and polyp screening.


Subject(s)
Gastric Bypass , Obesity, Morbid/epidemiology , Adult , Cholagogues and Choleretics/therapeutic use , Cholecystolithiasis/diagnostic imaging , Cholecystolithiasis/epidemiology , Duodenal Ulcer/epidemiology , Endoscopy, Digestive System , Female , Gallbladder/diagnostic imaging , Helicobacter Infections/epidemiology , Helicobacter pylori , Humans , Male , Middle Aged , Obesity, Morbid/surgery , Preoperative Care , Retrospective Studies , Stomach Ulcer/epidemiology , Ultrasonography , Ursodeoxycholic Acid/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...